Your session is about to expire
← Back to Search
Brain Stimulation for Memory Impairments in Epilepsy (MEMREINS Trial)
N/A
Waitlist Available
Led By Michael Kahana, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Subjects expected to undergo intracranial electroencephalographic monitoring as part of treatment for pharmacologically resistant epilepsy.
Be older than 18 years old
Must not have
Cognitive impairments limiting participation in memory testing
Physical disability limiting performance of cognitive tasks within normal limits
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 weeks (typical duration of hospital stay)
Awards & highlights
No Placebo-Only Group
Summary
This trial will study the effects of electrical brain stimulation on memory in patients with memory impairments.
Who is the study for?
This trial is for individuals with drug-resistant epilepsy who are already scheduled to have brain monitoring. Participants should be able to perform memory tests and give informed consent. It's not suitable for those with cognitive or physical disabilities affecting task performance, psychiatric conditions impacting consent, other serious medical issues, or pregnant women.
What is being tested?
The study uses direct electrical brain stimulation during verbal and spatial memory tasks to understand how the brain processes memories. This research involves multiple sites working together and participants will undergo experiments while being monitored.
What are the potential side effects?
While the description doesn't list specific side effects, direct electrical stimulation of the brain may cause discomfort at the stimulation site, temporary changes in mood or memory function, headaches, or seizures.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for brain monitoring due to hard-to-treat epilepsy.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have memory issues that may affect my participation in tests.
Select...
My physical disability does not affect my ability to think or understand.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 4 weeks (typical duration of hospital stay)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 weeks (typical duration of hospital stay)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
To assess how reactivation of prior memories shapes subsequent recall and memory organization, including memory for the content, context and value of experiences.
To determine how simultaneous stimulation at multiple target sites can be optimized to modulate memory
To determine whether state-dependent stimulation can separately be used to modulate encoding and retrieval processes
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Direct Electrical StimulationExperimental Treatment1 Intervention
Stimulation will be applied concurrently with the task, if applicable, and stimulation trials will be interleaved with sham trials, where no stimulation is delivered.
Find a Location
Who is running the clinical trial?
Columbia UniversityOTHER
1,492 Previous Clinical Trials
2,664,058 Total Patients Enrolled
10 Trials studying Epilepsy
2,757 Patients Enrolled for Epilepsy
Dartmouth CollegeOTHER
86 Previous Clinical Trials
1,418,936 Total Patients Enrolled
2 Trials studying Epilepsy
199 Patients Enrolled for Epilepsy
University of FreiburgOTHER
56 Previous Clinical Trials
23,873 Total Patients Enrolled
University of Colorado, DenverOTHER
1,808 Previous Clinical Trials
2,821,440 Total Patients Enrolled
7 Trials studying Epilepsy
1,242 Patients Enrolled for Epilepsy
University of PennsylvaniaLead Sponsor
2,082 Previous Clinical Trials
42,726,530 Total Patients Enrolled
3 Trials studying Epilepsy
667 Patients Enrolled for Epilepsy
Emory UniversityOTHER
1,704 Previous Clinical Trials
2,606,498 Total Patients Enrolled
10 Trials studying Epilepsy
1,317 Patients Enrolled for Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,381 Previous Clinical Trials
651,450 Total Patients Enrolled
80 Trials studying Epilepsy
25,561 Patients Enrolled for Epilepsy
University of Texas Southwestern Medical CenterOTHER
1,086 Previous Clinical Trials
1,057,862 Total Patients Enrolled
4 Trials studying Epilepsy
142 Patients Enrolled for Epilepsy
Thomas Jefferson UniversityOTHER
464 Previous Clinical Trials
174,949 Total Patients Enrolled
5 Trials studying Epilepsy
648 Patients Enrolled for Epilepsy
The University of Texas Health Science Center at San AntonioOTHER
476 Previous Clinical Trials
92,119 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a mental health condition that makes it hard for you to understand the study or complete tasks.I have memory issues that may affect my participation in tests.I am scheduled for brain monitoring due to hard-to-treat epilepsy.My physical disability does not affect my ability to think or understand.
Research Study Groups:
This trial has the following groups:- Group 1: Direct Electrical Stimulation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.